Table 1 Demographic characteristics of participants
From: Cognitive trajectories of patients with focal ß-amyloid deposition
Uptake grade | No-FMM uptake (n = 122) | Focal-FMM uptake (n = 45) | Diffuse-FMM uptake (n = 73) | p No vs Focal uptake | p No vs Diffuse uptake | p Focal vs Diffuse uptake |
|---|---|---|---|---|---|---|
Age (Mean ± SD) | 69.2 ± 8.6 | 73.6 ± 8.0 | 71.1 ± 8.4 | 0.008 | 0.360 | 0.341 |
Men (%) | 51 (41.8) | 13 (28.9) | 33 (45.2) | 0.387 | 1.000 | 0.236 |
Education, years (Mean ± SD) | 10.1 ± 5.0 | 10.3 ± 5.0 | 10.9 ± 4.5 | 1.000 | 0.822 | 1.000 |
APOE ε4 carrier (N = 236) | 17/119 (14.3) | 19/45 (42.2) | 40/72 (55.6) | < 0.001 | < 0.001 | 0.487 |
Vascular risk factors | ||||||
Hypertension (%) | 59 (48.4) | 19 (42.2) | 26 (35.6) | 1.000 | 0.250 | 1.000 |
Diabetes (%) | 20 (16.4) | 5 (11.1) | 11 (15.1) | 1.000 | 1.000 | 1.000 |
Hyperlipidemia (%) | 45 (36.9) | 14 (31.1) | 10 (13.7) | 1.000 | 0.002 | 0.069 |
Diagnosis | < 0.001 | < 0.001 | 0.005 | |||
CU (%) | 83 (68.0) | 19 (42.2) | 10 (13.7) | |||
aMCI (%) | 34 (27.9) | 11 (24.4) | 33 (45.2) | |||
ADD (%) | 5 (4.1) | 15 (33.3) | 30 (41.1) | |||